All the Active Ingredient Drugs
Human Anti-D Immunoglobulin 150 mcg/ml. VIALS (I.M.): 1 x 1 ml, 2 ml.
See lit.
I.M: Suppress. Rh immunizat. in non-sens.
Rho(D) -tve women delivering an Rho
+tve baby, or when the baby’s Rh is
unknown. Suppress. Rh immunizat. after
spontan. or induced abort., threatened
abort. See lit. To be given within 72 hrs of
event.
Human Anti-D Immunoglobulin 300 mcg / 2 ml. PREFILLED SYRINGE: 2 ml sol.
Antepartum proph: 1 x 300 μg I.V./I.M.
inject. 28-30 wks. gestat. Postpartum
proph: I.V: 200 μg; I.M: 200-300 μg. As
soon aft. delivery as poss., not later
than 72 hrs. postpartum. See lit.
Proph. foll. complicats. pregn:
Intervent., incid. up to 12 wks. gestat.
and chorion. villus sampling: 200 μg
I.V./I.M. as soon as poss., not later than
72 hrs. aft. at-risk event. Intervent.,
incid. aft. 12 wks. gestat: At least 200
μg I.V./I.M. as soon as poss., not later
than 72 hrs. aft. at-risk event.
Incompat. transfusions: 20 μg/2 ml
transfused Rh(D) positive blood I.V.
See lit.
Proph. Rh(D) immunizat. in Rh(D)
negative women, routine antepartum
proph., post. partum proph., complicats.
pregn. Tmt. Rh(D)-negative persons aft.
incompat. transfus. Rh(D)-positive
blood/erythrocyte concentrate.
C/I: Hypersens. See lit.
